newsfilter
← Latest News
GlobeNewswire·

Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference

BERKELEY, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou's